BIOPHTA
PrivateLast Round
Seed
Jun 3, 2024
Total Funding Raised
$7.84M
Company Overview
BIOPHTA is a preclinical-stage biotech company developing a technology for the treatment of eye diseases. Its ophthalmic insert technology is a mini-tablet that transforms into a hydrogel on the eye's surface, providing a continuous, controlled low dose of a drug for seven days.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIOPHTA Comparables
Compare BIOPHTA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EyeDura Therapeutics | 77% | |
| MediPrint Ophthalmics | 76% | |
| Synakis | 70% |
BIOPHTA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 3, 2024 | ||||
| Pre Seed | May 20, 2021 | ||||
| Accelerator | Oct 18, 2020 |
Key People
Founding team and executive leadership
BIOPHTA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GO Capital | Seed |
| Sofimac Investment Managers | Seed |
| Mérieux Equity Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors grew 110% MoM, reaching 1.1K.
- Jan 22, 2025
Grew 60% QoQ from 5 to 8 employees.
BIOPHTA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BIOPHTA's valuation, stock price, and market status.
Is BIOPHTA a public or private company?
BIOPHTA is a private company.
What is the current stock price of BIOPHTA?
BIOPHTA is a private company with no public stock price. No recent secondary market data is available.
How much is BIOPHTA worth (valuation)?
Valuation information for BIOPHTA is not publicly available.
Can I buy BIOPHTA stock?
BIOPHTA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BIOPHTA's last funding round?
BIOPHTA's most recent funding round was Seed on June 3, 2024.
Who are the main investors in BIOPHTA?
Key investors in BIOPHTA include GO Capital, Sofimac Investment Managers.
Will BIOPHTA IPO soon?
No public IPO plans have been announced for BIOPHTA.
How can I track BIOPHTA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BIOPHTA's secondary market activity and sign up for updates.